International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes
Recommendations
As issued by the authors
Evidence-based summary of recommendations for screening for risk of T1D and monitoring those with early-stage T1D
Review of clinical trials designed to delay progression to Stage 3 T1D and efforts to preserve beta-cell function in Stage 3 T1D
Opportunities and challenges of the recent US Food and Drug Administration (FDA) approval of teplizumab as an immunotherapy to delay progression are discussed
Original publication
ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. Published 11 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →